Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 1, 1998, Pages 90-97

  Bowler, J V ^a   Wade, J P H ^a   Jones, B E ^b   Nijran, K S ^b   Steiner, T J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Cerebral infarction; Natural history; Reperfusion; SPECT

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BRAIN; CEREBRAL INFARCTION; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPERFUSION INJURY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031980494     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.1.90     Document Type: Review

References (44)

1. Infeld B, Davis SM, Donnan GA, et al. Streptokinase increases luxury perfusion after stroke. Stroke 1996;27:1524-9.
2. Lassen NA. The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 1966;ii:1113-5.
3. Olsen TS, Larsen B, Skriver EB, Herning M, Enevoldsen E, Lassen NA. Focal cerebral hyperaemia in acute stroke. Incidence, pathophysiology and clinical significance. Stroke 1981;12:598-607.
4. Uemura K, Goto K, Ishii K, Ito Z, Hen R, Kawakami H. Sequential changes of regional cerebral blood circulation in cerebral infarction. Neuroradiology 1978;16:228-32.
5. Olsen TS, Lassen NA. A dynamic concept of middle cerebral artery occlusion and cerebral infarction in the acute state based on interpreting severe hyperemia as a sign of embolic migration. Stroke 1984;15:458-68.
6. Ackerman RH, Lev MH, Mackay BC, et al. PET studies in acute stroke. Findings and relevance to therapy. J Cereb Blood Flow Metab 1989;9(suppl 1):S359
7. Smith FW, Donald RT, Morris AJ, Sharp PF, Gemmell HG. The study of regional cerebral blood flow in stroke patients using technetium 99m HMPAO. Br J Radiol 1988;61:358-61.
8. Hakin AM, Pokrupa RP, Villanueva J, et al. The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts. Ann Neurol 1987;21:279-89.
9. Baird AE, Donnan GA, Austin M, Newton MR, McKay WJ. Preliminary experience with 99mTc-HMPAO SPECT in cerebral ischaemia. Clin Exp Neurol 1991;28:43-9.
10. Alexandrov AV, Ehrlich LE, Bladin CF, Black SE. Clinical significance of increased uptake of HMPAO on brain SPECT scans in acute stroke. J Neuroimaging 1996;6:150-5.
11. 2 inhalation steady-state method measured by positron emission tomography. J Cereb Blood Flow Metab 1988;8(suppl)S52-60.
12. Nakano S, Kinoshita K, Jinnouchi S, Hoshi H, Watanabe K. Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO. J Nucl Med 1989;30:157-64.
13. Yonekura Y, Nishizawa S, Mukai T, et al. SPECT with 99mTc-d,1-hexamethyl-propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET: effects of linearization. J Cereb Blood Flow Metab 1988;8(suppl):S82-9.
14. Costa DC, Jones BE, Steiner TJ, et al. Experimental studies of Tc 99m HMPAO with an rCBF model [abstract]. Nucl Med Commun 1986;7:282-3.
15. 133Xe. Nucl Med Commun 1987;8:549-57.
16. Bowler JV, Wade JPH, Jones BE, Nijran K, Steiner TJ. Single-photon emission computed tomography using hexamethlypropyleneamine oxime in the prognosis of acute cerebral infarction. Stroke 1996;27:82-6.
17. Davis SM, Chua MG, Lichtenstein M, Rossiter SC, Binns D, Hopper JL. Cerebral hypoperfusion in stroke prognosis and brain recovery. Stroke 1993;24:1691-6.
18. Alexandrov AV, Black SE, Ehrlich LE, et al. Simple visual analysis of brain perfusion on HMPAO SPECT predicts early outcome in acute stroke. Stroke 1996;27:1537-42.
19. Costa DC, Ell PJ. 99mTc-HMPAO washout in prognosis of stroke. Lancet 1989;1:213-4.
20. Bowler JV, Wade JPH, Jones BE, et al. The contribution of diaschisis to the clinical deficit in human cerebral infarction. Stroke 1995;26:1000-6.
21. Cote R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian neurological scale: a preliminary study in acute stroke. Stroke 1986;17:731-7.
22. Mahoney FI, Barthel DW. Functional evaluation; the Barthel index. Maryland State Medical Journal 1965;14:61-5.
23. m HMPAO SPECT [MD thesis]. London: University of London, 1993.
24. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-6.
25. Ackerman RH, Alpert NM, Correia JA, et al. Importance of monitoring metabolic function in assessing the severity of a stroke insult (CBF: an epiphenomenon?). J Cereb Blood Flow Metab 1981;1(suppl 1):S502-3.
26. 99mTc-HMPAO washout in prognosis of stroke. Lancet 1989;i:839-840.
27. Limbing M, van Royen EA, Hijdra A, Verbeeten B. rCBF-SPECT in brain infarction: when does it predict outcome? J Nucl Med 1991;32:382-7.
28. Baron JC, Bousser MG, Comar D, Soussaline F, Castaigne P. Non-invasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Eur Neurol 1981;20:273-84.
29. Suess E, Huck S. 99m Tc HMPAO accumulation in cultured neurons. J Cereb Blood Flow Metab 1989;9(suppl 1):S735.
30. Neirinckx RD, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen NA. The retention mechanism of technetium 99m HMPAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab 1988;8(suppl):S4-12.
31. Jacquicr-Sarlin MR. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO. J Nucl Med 1996;37:1413-6.
32. Sperling B, Lassen NA. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of CBF by SPECT. Stroke 1993;24:193-4.
33. 2 and 99mTc-HMPAO imaging. Ann Nucl Med 1995;9:161-6.
34. 123I-IMP SPECT imaging during the subacute phase of stroke. Eur J Nucl Med 1990;16:17-22.
35. 99mTc-hexamethypropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia. J Neurol 1990;237: 475-9.
36. Marchai G, Serrati C, Rioux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet 1993;341: 925-7.
37. Demeurisse G, Verhas M, Capon A, Paternot J. Lack of evolution of the cerebral blood flow during clinical recovery of a stroke. Stroke 1983;14:77-81.
38. Heiss WD, Huber M, Fink GR, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193-203.
39. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke 1996;27: 761-5.
40. Brott T, Marier JR, Olinger CP, et al. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 1989;20:871-5.
41. Rango M, Candelise L, Perani D, et al. Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography. Arch Neurol 1989;46: 1318-22.
42. Yamaguchi T, Minematsu K, Choki J, Ikeda M. Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 1984;48:50-8.
43. Hayashida K, Nishimura T, Imakita S, Uehara T. Filling out phenomenon with technetium-99m HM-PAO brain SPECT at the site of mild cerebral ischemia. J Nucl Med 1989;30:591-8.
44. Podreka I, Suess E, Goldenberg G, et al. Initial experience with technetium-99m HM-PAO brain SPECT. J Nucl Med 1987;28:1657-66.